Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 17/20 | 0.52 |
| ▸ | RAMP3 | O60896 | 14/20 | 0.52 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.47 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30906395 | 0.88 | CALCR (0.53) | CALCRRAMP3 | |
| SCHEMBL30906390 | 0.86 | CALCR (0.52) | CALCRRAMP3 | |
| SCHEMBL30906351 | 0.86 | CALCR (0.52) | CALCRRAMP3 | |
| SCHEMBL30906479 | 0.86 | CALCR (0.50) | CALCRRAMP3CRHR1CRHR2 | |
| SCHEMBL31182985 | 0.85 | CALCR (0.51) | CALCRRAMP3 | |
| SCHEMBL30906512 | 0.85 | CALCR (0.53) | CALCRRAMP3CRHR1CRHR2 | |
| SCHEMBL30432851 | 0.84 | RAMP3 (0.60) | CALCRRAMP3 | |
| SCHEMBL30930146 | 0.84 | RAMP3 (0.55) | CALCRRAMP3 | |
| SCHEMBL31433327 | 0.84 | CALCR (0.47) | CALCRRAMP3 | |
| SCHEMBL31603948 | 0.83 | CAPN1 (0.54) | CALCRRAMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4642484-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | disclosed |
| WO-2024239281-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2024-11-28 | — | — | WO | disclosed |